Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$24.02 - $43.89 $698,357 - $1.28 Million
29,074 New
29,074 $1.17 Million
Q3 2021

Nov 09, 2021

SELL
$46.87 - $64.24 $1.1 Million - $1.51 Million
-23,432 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$46.47 - $63.93 $596,535 - $820,669
-12,837 Reduced 35.39%
23,432 $1.25 Million
Q1 2021

May 14, 2021

BUY
$55.47 - $72.35 $2.01 Million - $2.62 Million
36,269 New
36,269 $2.23 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.92B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.